Aims to achieve an attractive level of income combined with capital growth.
Name | % Net Assets |
---|---|
British American Tobacco | 4.6% |
HSBC | 3.9% |
Royal Dutch Shell 'B' | 3.9% |
Centrica | 3.6% |
AstraZeneca | 3.6% |
GlaxoSmithKline | 3.6% |
BP | 3.5% |
Vodafone | 3.4% |
Aviva | 3.1% |
National Grid | 3.0% |
Key | % Net Assets |
---|---|
British American Tobacco | 4.6% |
HSBC | 3.9% |
Royal Dutch Shell 'B' | 3.9% |
Centrica | 3.6% |
Other | 84% |
Date | 30-Oct-2024 |
---|---|
NAV | 1,525.27p |
Currency | GBP |
Change | -18.27p |
% | -1.18% |
YTD change | 34.62p |
YTD % | 2.32% |
Fund Inception | 07/04/2006 |
---|---|
Fund Manager | Pan European Equities Team |
TER | - |
Minimum Investment | |
---|---|
Initial | £500 |
Additional | £100 |
Savings | £50 |
Charges | |
---|---|
Initial | 4.25% |
Annual Mang't | 1.50% |
Exit | n/a |
Name | % |
---|---|
No risk data available. |
You are here: research